CDH2 and breast cancer: In breast cancer, N-cadherin interacts with fibroblast growth factor receptor (FGFR) (35), activates signal pathways, and induces the expression of matrix metalloproteinase-9 (MMP-9) (36), thereby promoting tumor invasion and metastasis (20, 35).